Federal contract award
75N93019F00132
CONTRACT HHSN272201800009I ADVANCED BIOSCIENCE LABORATORIIES, INC. OLOGY BASE AWARDPROCESS DEVELOPMENT AND MANUFACTURE OF CGMP COMPLIANT B19 PARVOVIRUS VACCINE DRUG PRODUCT FOR USE IN PHASE I/II CLINICAL TRIALSIID CAN 84702151,803.970
Award details
Obligations, current value and potential value describe different measures; they are never added together.
| Field | Reported value |
|---|---|
| Agency | Department of Health and Human Services |
| Office | NATIONAL INSTITUTES OF HEALTH NIAID |
| NAICS | 541714 — Research and Development in Biotechnology (except Nanobiotechnology) |
| PSC | AN12 — HEALTH R&D SERVICES; HEALTH CARE SERVICES; APPLIED RESEARCH |
| Parent award / vehicle | 75N93018D00009 |
| Set-aside | Not reported |
| Pricing type | FIRM FIXED PRICE |
| Obligations | $1.7M |
| Current contract value | $1.7M |
| Potential contract value / ceiling | $1.7M |
| Start date | Aug 14, 2019 |
| Current end date | Apr 15, 2025 |
| Potential end date | Apr 15, 2025 |
| Latest award activity | Apr 21, 2025 |
| Source loaded | Aug 15, 2026 |
Funding and modification history
Showing the latest 1 of 1 loaded transactions. Negative values are deobligations.
| Date | Modification | Obligation change | Description |
|---|---|---|---|
| Apr 21, 2025 | P00003 | $0 | EOI::IMPLEMENTING THE PRESIDENTS DEPARTMENT OF GOVERNMENT EFFICIENCY COST EFFICIENCY INITIATIVE (MARCH 19, 2025)::EOI TO FULLY TERMINATE THIS CONTRACT FOR CONVENIENCE, EFFECTIVE APRIL 15, 2025, PURSUANT TO 52.249-6 TERMINATION (COST-REIMBURSEMENT). |
Research next steps
- Confirm the ordering vehicle and your eligibility or a qualified teaming route.
- Review the award scope and buyer evidence before making a bid/no-bid decision.